ONTOLOGY REPORT - ANNOTATIONS
Term: Endometrial Neoplasms
Accession: RDO:0007008
browse the term
Definition: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
Synonyms: exact_synonym: Cancer of Endometrium; Cancer of the Endometrium; Carcinoma of Endometrium; Endometrial Cancer; Endometrial Cancers; Endometrial Carcinoma; Endometrial Carcinomas; Endometrial Neoplasm; Endometrium Cancer; Endometrium Cancers; Endometrium Carcinoma; Endometrium Carcinomas
primary_id: MESH:D016889
alt_id: OMIM:192090 ; OMIM:601728 ; OMIM:608089
Endometrial Neoplasms
G
Adrb3
adrenoceptor beta 3
Susceptibility
ISS
16
69,163,620
69,166,384
RGD:2313164
RGD
G
Afp
alpha-fetoprotein
Severity
ISS
14
19,092,563
19,110,728
RGD:2292039
RGD
G
Amhr2
anti-Mullerian hormone receptor, type II
ISS
7
141,203,832
141,212,653
RGD:2315651
RGD
G
Ang
angiogenin, ribonuclease, RNase A family, 5
ISS
15
27,083,089
27,083,526
RGD:2317659
RGD
G
Angpt1
angiopoietin 1
ISS
7
78,195,504
78,451,471
RGD:2293852
RGD
G
Angpt2
angiopoietin 2
ISS
16
75,891,757
75,942,255
RGD:2293852
RGD
G
Apex1
APEX nuclease (multifunctional DNA repair enzyme) 1
ISS
15
26,904,124
26,906,224
RGD:2315878
RGD
G
Ar
androgen receptor
ISS
X
85,949,507
86,119,199
RGD:1578689
RGD
G
Atm
ataxia telangiectasia mutated
Susceptibility
ISS
8
56,894,746
56,996,565
RGD:2293868
RGD
G
Aurka
aurora kinase A
ISS
3
163,270,479
163,284,506
RGD:2293878
RGD
G
Aurkb
aurora kinase B
Disease_progression
ISS
10
55,798,710
55,804,367
RGD:2293878
RGD
G
Bag1
BCL2-associated athanogene
ISS
5
58,329,720
58,342,293
RGD:2293886
RGD
G
Bcl2
B-cell CLL/lymphoma 2
Severity
ISS
13
12,730,736
12,905,108
RGD:2298890
RGD
G
Bcl2l1
Bcl2-like 1
ISS
3
143,129,087
143,180,199
RGD:1643476
RGD
G
Brca2
breast cancer 2, early onset
ISS
12
4,282,952
4,323,693
RGD:2296027
RGD
G
Bsg
basigin (Ok blood group)
Disease_progression
ISS
7
11,507,914
11,515,132
RGD:2296029
RGD
G
Calb2
calbindin 2
ISS
19
40,023,072
40,051,150
RGD:2315881
RGD
G
Ccnb1
cyclin B1
ISS
2
31,574,600
31,581,784
RGD:2289230
RGD
G
Ccnd1
cyclin D1
ISS
1
205,357,235
205,366,757
RGD:2296034
RGD
G
Cd44
Cd44 molecule
ISS
3
88,022,962
88,110,352
RGD:2289358
RGD
G
Cd44
Cd44 molecule
Disease_progression
ISS
3
88,022,962
88,110,352
RGD:2296044
RGD
G
Cd46
CD46 molecule, complement regulatory protein
ISS
13
110,972,812
111,003,407
RGD:2293548
RGD
G
Cd55
Cd55 molecule
ISS
13
43,322,246
43,348,334
RGD:2326173
RGD
G
Cd59
CD59 molecule, complement regulatory protein
ISS
3
89,243,600
89,245,129
RGD:2293548
RGD
G
Cd82
Cd82 molecule
Disease_progression
ISS
3
77,831,771
77,875,764
RGD:2289403
RGD
G
Cd9
CD9 molecule
ISS
4
162,279,462
162,312,889
RGD:2326208
RGD
G
Cdc25b
cell division cycle 25B
ISS
3
118,893,716
118,903,516
RGD:4105451
RGD
G
Cdc25c
cell division cycle 25C
ISS
18
27,206,537
27,225,811
RGD:4105452
RGD
G
Cdc25c
cell division cycle 25C
ISS
18
27,206,537
27,225,811
RGD:4105455
RGD
G
Cdh1
cadherin 1
ISS
19
36,442,693
36,512,091
RGD:7240710
OMIM
G
Cdh13
cadherin 13
Disease_progression
ISS
19
48,507,173
49,575,123
RGD:2298985
RGD
G
Cdk2
cyclin dependent kinase 2
Disease_progression
ISS
7
2,000,196
2,007,682
RGD:2289230
RGD
G
Cdk4
cyclin-dependent kinase 4
Disease_progression
ISS
RGD:2299055
RGD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
Susceptibility
ISS
20
7,376,325
7,386,778
RGD:2296047
RGD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
ISS
20
7,376,325
7,386,778
RGD:2289683
RGD
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISS
4
171,841,705
171,846,506
RGD:2299090
RGD
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
Severity
ISS
5
108,908,749
108,916,380
RGD:2289683
RGD
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
IAGP
5
108,908,749
108,916,380
RGD:2316081
RGD
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
Severity
ISS
RGD:2289683
RGD
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
IAGP
5
108,939,669
108,945,293
RGD:2316081
RGD
G
Chi3l1
chitinase 3-like 1 (cartilage glycoprotein-39)
Severity
ISS
13
47,139,658
47,147,591
RGD:4892642
RGD
G
Comt
catechol-O-methyltransferase
No_Association
ISS
11
84,561,591
84,581,713
RGD:2289721
RGD
G
Comt
catechol-O-methyltransferase
ISS
11
84,561,591
84,581,713
RGD:2289723
RGD
G
Comt
catechol-O-methyltransferase
Susceptibility
ISS
11
84,561,591
84,581,713
RGD:2289714
RGD
G
Ctnna1
catenin (cadherin-associated protein), alpha 1, 102kDa
Disease_progression
ISS
18
27,629,915
27,769,360
RGD:2298485
RGD
G
Ctnnb1
catenin (cadherin associated protein), beta 1
ISS
8
125,978,161
125,987,670
RGD:4143515
RGD
G
Ctnnb1
catenin (cadherin associated protein), beta 1
ISS
8
125,978,161
125,987,670
RGD:2289828
RGD
G
Ctnnb1
catenin (cadherin associated protein), beta 1
Disease_progression
ISS
8
125,978,161
125,987,670
RGD:2298485
RGD
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISS
RGD:2301045
RGD
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISS
8
61,462,207
61,468,237
RGD:2301040
RGD
G
Ebag9
estrogen receptor binding site associated, antigen, 9
ISS
7
80,515,272
80,533,346
RGD:2289850
RGD
G
Erap1
endoplasmic reticulum aminopeptidase 1
Disease_progression
ISS
2
1,453,878
1,492,671
RGD:2315693
RGD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
Disease_progression
ISS
10
87,219,157
87,242,919
RGD:2298490
RGD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
Severity
ISS
10
87,219,157
87,242,919
RGD:2298491
RGD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
ISS
10
87,219,157
87,242,919
RGD:4143515
RGD
G
Erbb3
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
ISS
7
1,858,057
1,877,353
RGD:2298505
RGD
G
Erbb4
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
ISS
9
66,843,898
67,967,970
RGD:2298505
RGD
G
Fgf1
fibroblast growth factor 1 (acidic)
Disease_progression
ISS
18
31,785,480
31,806,452
RGD:2298516
RGD
G
Fgf2
fibroblast growth factor 2
Disease_progression
ISS
2
123,893,314
123,947,136
RGD:2298516
RGD
G
Fgf7
fibroblast growth factor 7
ISS
3
113,468,427
113,517,538
RGD:2301091
RGD
G
Fgfr2
fibroblast growth factor receptor 2
ISS
1
189,482,975
189,589,279
RGD:2301189
RGD
G
Fgfr2
fibroblast growth factor receptor 2
Susceptibility
ISS
1
189,482,975
189,589,279
RGD:2301188
RGD
G
Fhit
fragile histidine triad
ISS
15
15,823,461
17,329,184
RGD:2289899
RGD
G
Flt1
FMS-related tyrosine kinase 1
Severity
ISS
12
7,858,092
8,035,966
RGD:2301252
RGD
G
Flt1
FMS-related tyrosine kinase 1
Disease_progression
ISS
12
7,858,092
8,035,966
RGD:2301256
RGD
G
Ghrh
growth hormone releasing hormone
ISS
3
148,027,235
148,046,352
RGD:2301423
RGD
G
Ghrh
growth hormone releasing hormone
ISS
3
148,027,235
148,046,352
RGD:2301425
RGD
G
Ghrh
growth hormone releasing hormone
ISS
3
148,027,235
148,046,352
RGD:2289974
RGD
G
Gpx3
glutathione peroxidase 3
IEP
10
40,311,094
40,319,382
RGD:2312621
RGD
G
H19
H19, imprinted maternally expressed transcript (non-protein coding)
Severity
ISS
1
202,822,925
202,825,601
RGD:2306178
RGD
G
Hdac1
histone deacetylase 1
Disease_progression
ISS
5
148,672,515
148,699,810
RGD:2306205
RGD
G
Hdac2
histone deacetylase 2
Disease_progression
ISS
20
41,162,093
41,186,492
RGD:2306205
RGD
G
Hdac3
histone deacetylase 3
Disease_progression
ISS
18
30,857,209
30,875,986
RGD:2306205
RGD
G
Hoxb13
homeo box B13
ISS
10
84,925,520
84,927,793
RGD:2314730
RGD
G
Htra2
HtrA serine peptidase 2
ISS
4
117,262,206
117,265,368
RGD:5688747
RGD
G
Igfbp3
insulin-like growth factor binding protein 3
ISS
14
87,959,153
87,967,085
RGD:2290018
RGD
G
Il10
interleukin 10
ISS
13
43,953,900
43,957,766
RGD:2317659
RGD
G
Inha
inhibin alpha
ISS
9
74,781,223
74,784,124
RGD:1579943
RGD
G
Irf1
interferon regulatory factor 1
IAGP
10
39,220,600
39,227,602
RGD:5128782
RGD
G
Jag1
jagged 1
ISS
3
125,181,063
125,216,481
RGD:2299152
RGD
G
Jun
jun proto-oncogene
No_Association
ISS
5
115,358,166
115,361,259
RGD:2290482
RGD
G
Jun
jun proto-oncogene
Disease_progression
ISS
5
115,358,166
115,361,259
RGD:2290481
RGD
G
Jup
junction plakoglobin
ISS
10
89,307,938
89,335,254
RGD:2301747
RGD
G
Kdr
kinase insert domain receptor
ISS
RGD:2301252
RGD
G
Kdr
kinase insert domain receptor
Disease_progression
ISS
RGD:2301760
RGD
G
Kiss1
KiSS-1 metastasis-suppressor
Disease_progression
ISS
13
46,244,786
46,247,288
RGD:2302170
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ISS
4
182,869,242
182,895,106
RGD:4143515
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
IAGP
4
182,869,242
182,895,106
RGD:1600499
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ISS
4
182,869,242
182,895,106
RGD:2314907
RGD
G
Lnpep
leucyl/cystinyl aminopeptidase
ISS
1
56,063,361
56,151,257
RGD:2314921
RGD
G
Lta
lymphotoxin alpha (TNF superfamily, member 1)
Susceptibility
ISS
20
3,657,842
3,659,848
RGD:2313259
RGD
G
Met
met proto-oncogene
IAGP
4
43,134,183
43,211,355
RGD:70557
RGD
G
Mlh1
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)
ISS
8
115,616,396
115,653,471
RGD:4143515
RGD
G
Mlh3
mutL homolog 3 (E. coli)
ISS
6
109,280,910
109,318,893
RGD:7240710
OMIM
G
Mmp2
matrix metallopeptidase 2
Disease_progression
ISS
19
15,246,036
15,275,061
RGD:2290360
RGD
G
Mmp7
matrix metallopeptidase 7
Disease_progression
ISS
8
4,526,018
4,533,730
RGD:2298522
RGD
G
Mmp8
matrix metallopeptidase 8
ISS
8
4,402,124
4,410,976
RGD:2306086
RGD
G
Mmp9
matrix metallopeptidase 9
Disease_progression
ISS
3
155,985,473
155,993,433
RGD:2298523
RGD
G
Mre11a
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
ISS
8
11,588,409
11,632,483
RGD:2317737
RGD
G
Msh2
mutS homolog 2 (E. coli)
ISS
6
11,199,906
11,258,350
RGD:2298951
RGD
G
Msh2
mutS homolog 2 (E. coli)
ISS
6
11,199,906
11,258,350
RGD:2293523
RGD
G
Msh3
mutS homolog 3 (E. coli)
ISS
2
22,462,934
22,606,874
RGD:1600456
RGD
G
Msh6
mutS homolog 6 (E. coli)
ISS
6
11,525,292
11,542,592
RGD:7240710
OMIM
G
Ncoa1
nuclear receptor coactivator 1
ISS
6
27,224,396
27,473,926
RGD:2298984
RGD
G
Ncor2
nuclear receptor co-repressor 2
ISS
12
32,617,643
32,725,753
RGD:2298984
RGD
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
ISS
10
82,591,705
82,601,075
RGD:2299066
RGD
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
ISS
10
82,582,766
82,588,269
RGD:2299066
RGD
G
Nos3
nitric oxide synthase 3, endothelial cell
Disease_progression
ISS
4
6,158,847
6,179,441
RGD:2292090
RGD
G
Notch1
notch 1
ISS
3
4,631,797
4,677,640
RGD:2299153
RGD
G
Notch4
notch 4
ISS
20
4,263,205
4,287,312
RGD:2299153
RGD
G
Pgm1
phosphoglucomutase 1
ISS
5
120,595,650
120,655,915
RGD:2299870
RGD
G
Phb
prohibitin
ISS
RGD:2292406
RGD
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISS
2
118,640,277
118,672,440
RGD:4143515
RGD
G
Prkca
protein kinase C, alpha
ISS
10
97,367,196
97,638,910
RGD:2292462
RGD
G
Pten
phosphatase and tensin homolog
ISS
1
236,771,027
236,837,261
RGD:4143515
RGD
G
Pten
phosphatase and tensin homolog
Severity
ISS
1
236,771,027
236,837,261
RGD:2292506
RGD
G
Pten
phosphatase and tensin homolog
ISS
1
236,771,027
236,837,261
RGD:7240710
OMIM
G
Ptges
prostaglandin E synthase
ISS
3
9,946,194
9,957,538
RGD:2300089
RGD
G
Ptgs1
prostaglandin-endoperoxide synthase 1
Disease_progression
ISS
3
15,343,832
15,365,412
RGD:2300125
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
Disease_progression
ISS
13
64,427,288
64,432,978
RGD:2300125
RGD
G
Ptk2
protein tyrosine kinase 2
Severity
ISS
7
110,933,298
111,084,554
RGD:2292562
RGD
G
Rassf1
Ras association (RalGDS/AF-6) domain family member 1
ISS
8
112,798,863
112,810,004
RGD:2299863
RGD
G
Rb1
retinoblastoma 1
ISS
15
53,828,881
53,962,099
RGD:2299055
RGD
G
Rel
v-rel reticuloendotheliosis viral oncogene homolog (avian)
ISS
14
104,645,370
104,671,275
RGD:2300268
RGD
G
Rrm2
ribonucleotide reductase M2
IAGP
6
42,350,541
42,356,748
RGD:2324953
RGD
G
Runx3
runt-related transcription factor 3
ISS
5
153,950,116
153,973,141
RGD:2302555
RGD
G
Sfn
stratifin
ISS
5
151,475,395
151,479,996
RGD:2299931
RGD
G
Shbg
sex hormone binding globulin
ISS
10
56,432,474
56,435,654
RGD:1625245
RGD
G
Skp2
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
ISS
2
58,769,164
58,797,229
RGD:2315045
RGD
G
Smad2
SMAD family member 2
ISS
18
73,180,520
73,241,707
RGD:2299970
RGD
G
Smad3
SMAD family member 3
ISS
8
67,803,909
67,952,056
RGD:2299970
RGD
G
Smad4
SMAD family member 4
ISS
18
70,432,705
70,461,541
RGD:2300009
RGD
G
Smad4
SMAD family member 4
Severity
ISS
18
70,432,705
70,461,541
RGD:2299966
RGD
G
Smad7
SMAD family member 7
Disease_progression
ISS
18
72,294,803
72,323,354
RGD:2299963
RGD
G
Socs2
suppressor of cytokine signaling 2
ISS
7
32,605,714
32,608,323
RGD:2298926
RGD
G
Sparc
secreted protein, acidic, cysteine-rich (osteonectin)
ISS
10
40,809,730
40,831,481
RGD:2300020
RGD
G
Spink1
serine peptidase inhibitor, Kazal type 1
ISS
18
37,090,934
37,099,835
RGD:2300389
RGD
G
St14
suppression of tumorigenicity 14 (colon carcinoma)
Disease_progression
ISS
8
30,916,769
30,932,214
RGD:2315087
RGD
G
Stat3
signal transducer and activator of transcription 3 (acute-phase response factor)
ISS
10
89,821,078
89,872,970
RGD:1643476
RGD
G
Stk11
serine/threonine kinase 11
ISS
7
11,086,760
11,103,522
RGD:2291944
RGD
G
Stk11
serine/threonine kinase 11
ISS
7
11,086,760
11,103,522
RGD:2291944
RGD
G
Sult1a1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
ISS
1
185,829,205
185,832,725
RGD:1581436
RGD
G
Sult1a1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
No_Association
ISS
1
185,829,205
185,832,725
RGD:2301045
RGD
G
Sult1a1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
ISS
1
185,829,205
185,832,725
RGD:2301040
RGD
G
Sult1e1
sulfotransferase family 1E, estrogen-preferring, member 1
ISS
14
21,948,475
21,965,541
RGD:2301040
RGD
G
Tert
telomerase reverse transcriptase
ISS
1
30,445,180
30,465,942
RGD:2298562
RGD
G
Tff1
trefoil factor 1
Disease_progression
ISS
20
9,526,674
9,530,534
RGD:2298572
RGD
G
Tff1
trefoil factor 1
ISS
20
9,526,674
9,530,534
RGD:2298569
RGD
G
Tgfbr3
transforming growth factor, beta receptor III
ISS
14
3,051,039
3,240,286
RGD:1579943
RGD
G
Timp1
TIMP metallopeptidase inhibitor 1
Disease_progression
ISS
X
12,542,496
12,547,094
RGD:2298523
RGD
G
Timp2
TIMP metallopeptidase inhibitor 2
Disease_progression
ISS
10
108,310,473
108,358,821
RGD:2290360
RGD
G
Timp3
TIMP metallopeptidase inhibitor 3
Disease_progression
ISS
7
19,677,144
19,727,072
RGD:2290420
RGD
G
Timp4
tissue inhibitor of metalloproteinase 4
ISS
4
151,375,072
151,381,591
RGD:2290435
RGD
G
Timp4
tissue inhibitor of metalloproteinase 4
Disease_progression
ISS
4
151,375,072
151,381,591
RGD:2290420
RGD
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
ISS
4
162,172,563
162,185,252
RGD:5131439
RGD
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISS
5
163,666,541
163,697,484
RGD:5131439
RGD
G
Tp53
tumor protein p53
ISS
10
56,399,721
56,411,150
RGD:4143515
RGD
G
Tp53
tumor protein p53
Severity
ISS
10
56,399,721
56,411,150
RGD:2298525
RGD
G
Tp53
tumor protein p53
ISS
10
56,399,721
56,411,150
RGD:2290541
RGD
G
Tp73
tumor protein p73
ISS
5
170,848,979
171,078,739
RGD:2290585
RGD
G
Tp73
tumor protein p73
Susceptibility
ISS
5
170,848,979
171,078,739
RGD:2298528
RGD
G
Tsg101
tumor susceptibility gene 101
ISS
1
97,445,040
97,475,141
RGD:2291854
RGD
G
Tymp
thymidine phosphorylase
ISS
7
127,666,518
127,671,624
RGD:2293715
RGD
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
ISS
9
87,091,241
87,098,362
RGD:2315450
RGD
G
Wnt2
wingless-type MMTV integration site family member 2
ISS
4
43,649,783
43,689,596
RGD:2291875
RGD
G
Wnt3
wingless-type MMTV integration site family, member 3
ISS
10
92,925,605
92,969,613
RGD:2291875
RGD
G
Wnt4
wingless-type MMTV integration site family, member 4
ISS
5
156,064,371
156,083,198
RGD:2291875
RGD
G
Wnt5a
wingless-type MMTV integration site family, member 5A
ISS
16
3,782,025
3,799,625
RGD:2291875
RGD
G
Wt1
Wilms tumor 1
Disease_progression
ISS
3
90,529,704
90,577,280
RGD:2315542
RGD
Q
Edcs1
Endometrial carcinoma susceptibility QTL1
Susceptibility
IED
11
19,445,919
24,982,397
RGD:1599856
RGD
Q
Edcs2
Endometrial carcinoma susceptibility QTL2
Susceptibility
IED
12
7,382,953
27,853,771
RGD:1599856
RGD
Q
Edcs3
Endometrial carcinoma susceptibility QTL3
Susceptibility
IED
20
1,675,005
2,780,205
RGD:1599856
RGD
Q
Edcs4
Endometrial carcinoma susceptibility QTL 4
Susceptibility
IED
1
221,868,279
247,322,277
RGD:1599856
RGD
Q
Edcs5
Endometrial carcinoma susceptibility QTL 5
Susceptibility
IED
17
65,900,398
82,125,463
RGD:1599856
RGD
S
BDII/Ztm
Spontaneous
TAS
RGD:1599853
RGD
S
DA
DA
TAS
RGD:1004
RGD
S
LEW
Lewis
TAS
RGD:1004
RGD
S
M520
TAS
RGD:1004
RGD
S
M520/N
TAS
RGD:1004
RGD
Carcinoma, Endometrioid
G
Areg
amphiregulin
ISS
14
18,466,313
18,475,571
RGD:2289950
RGD
G
Atp7b
ATPase, Cu++ transporting, beta polypeptide
Disease_progression
ISS
16
74,607,988
74,680,080
RGD:2298864
RGD
G
Birc5
baculoviral IAP repeat-containing 5
ISS
RGD:2298940
RGD
G
Bmp4
bone morphogenetic protein 4
ISS
15
22,283,171
22,286,757
RGD:2296026
RGD
G
Car9
carbonic anhydrase 9
ISS
5
59,986,413
59,993,015
RGD:2298945
RGD
G
Ccne1
cyclin E1
ISS
1
90,568,189
90,577,426
RGD:2289230
RGD
G
Cdh1
cadherin 1
ISS
19
36,442,693
36,512,091
RGD:2296045
RGD
G
Cdk2
cyclin dependent kinase 2
Severity
ISS
7
2,000,196
2,007,682
RGD:2298990
RGD
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISS
4
171,841,705
171,846,506
RGD:2299091
RGD
G
Chek2
checkpoint kinase 2
Susceptibility
ISS
12
45,933,900
45,965,427
RGD:2293868
RGD
G
Ctnnb1
catenin (cadherin associated protein), beta 1
ISS
8
125,978,161
125,987,670
RGD:2289817
RGD
G
Egfr
epidermal growth factor receptor
ISS
14
97,617,358
97,788,211
RGD:2289950
RGD
G
Eno2
enolase 2, gamma, neuronal
ISS
4
160,891,003
160,897,723
RGD:2293737
RGD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
ISS
10
87,219,157
87,242,919
RGD:2289950
RGD
G
Erbb3
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
ISS
7
1,858,057
1,877,353
RGD:2289950
RGD
G
Erbb4
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
ISS
9
66,843,898
67,967,970
RGD:2289950
RGD
G
Fgfr2
fibroblast growth factor receptor 2
ISS
1
189,482,975
189,589,279
RGD:2289862
RGD
G
Igfbp3
insulin-like growth factor binding protein 3
Disease_progression
ISS
14
87,959,153
87,967,085
RGD:2301465
RGD
G
Inha
inhibin alpha
ISS
9
74,781,223
74,784,124
RGD:2290368
RGD
G
Inhba
inhibin beta-A
ISS
17
57,244,466
57,257,531
RGD:2301688
RGD
G
Kdr
kinase insert domain receptor
Severity
ISS
RGD:2291929
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ISS
4
182,869,242
182,895,106
RGD:2314910
RGD
G
Lnpep
leucyl/cystinyl aminopeptidase
ISS
1
56,063,361
56,151,257
RGD:2314922
RGD
G
Nkx2-1
NK2 homeobox 1
ISS
6
76,916,943
76,920,133
RGD:2290483
RGD
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISS
14
35,369,422
35,418,126
RGD:2298578
RGD
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISS
18
57,014,475
57,053,581
RGD:2298578
RGD
G
Pten
phosphatase and tensin homolog
ISS
1
236,771,027
236,837,261
RGD:2289817
RGD
G
Spp1
secreted phosphoprotein 1
ISS
RGD:1581360
RGD
G
St14
suppression of tumorigenicity 14 (colon carcinoma)
ISS
8
30,916,769
30,932,214
RGD:2315091
RGD
G
Wif1
Wnt inhibitory factor 1
ISS
7
60,330,517
60,400,697
RGD:2298535
RGD
Q
Edcs1
Endometrial carcinoma susceptibility QTL1
Susceptibility
IED
11
19,445,919
24,982,397
RGD:1599856
RGD
Q
Edcs2
Endometrial carcinoma susceptibility QTL2
Susceptibility
IED
12
7,382,953
27,853,771
RGD:1599856
RGD
Q
Edcs3
Endometrial carcinoma susceptibility QTL3
Susceptibility
IED
20
1,675,005
2,780,205
RGD:1599856
RGD
Q
Edcs4
Endometrial carcinoma susceptibility QTL 4
Susceptibility
IED
1
221,868,279
247,322,277
RGD:1599856
RGD
Q
Edcs5
Endometrial carcinoma susceptibility QTL 5
Susceptibility
IED
17
65,900,398
82,125,463
RGD:1599856
RGD
S
BDII/Ztm
Spontaneous
TAS
RGD:1599853
RGD
S
BDII/Ztm
Model
IAGP
RGD:1599853
RGD
Sarcoma, Endometrial Stromal
G
Kit
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
ISS
14
34,906,043
34,984,819
RGD:2292170
RGD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest